tiprankstipranks
Regencell Bioscience Holdings Ltd. (RGC)
:RGC
US Market

Regencell Bioscience (RGC) Income Statement

Compare
38 Followers

Regencell Bioscience Income Statement

Last quarter (Q2 2024), Regencell Bioscience's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Regencell Bioscience's net income was $―. See Regencell Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -745.59K$ -769.69K$ -604.40K$ -26.46K-
Operating Expenses
$ 3.99M$ 6.27M$ 7.62M$ 1.38M$ 812.37K
Depreciation and Amortization
$ 745.59K$ 769.69K$ 604.40K$ 26.46K-
EBITDA
$ -3.62M$ -5.29M$ -6.99M$ -1.35M$ -802.86K
Operating Income
$ -4.74M$ -6.27M$ -7.62M$ -1.38M$ -812.37K
Other Income/Expenses
$ 373.50K$ 211.34K$ 23.21K$ 34.62K$ 0.00
Pretax Income
$ -4.36M$ -6.06M$ -7.59M$ -1.35M$ -812.37K
Net Income
$ -4.30M$ -5.87M$ -7.42M$ -1.35M$ -812.37K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.33$ -0.45$ -0.57$ -0.11$ -0.06
Diluted EPS
$ -0.33$ -0.45$ -0.57$ -0.11$ -0.06
Weighted Average Shares Outstanding
13.01M 13.01M 13.01M 12.64M 12.64M
Weighted Average Shares Outstanding (Diluted)
13.01M 13.01M 13.01M 12.64M 12.64M
Currency in USD

Regencell Bioscience Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis